Abstract

As cancer therapies boost, sufferers are living longer. With these improvements in therapy comes a duty to optimize patients’ good quality of life during cancer therapy and beyond. This report evaluations 3 timely and critical subjects. The 1st section evaluations the mechanism underlying chemotherapy-induced peripheral neuropathy and evaluates the proof for interventions to avoid and treat peripheral neuropathy. It also gives a framework for approaching the diagnosis and management of this prevalent and bothersome side impact. The second section addresses the controversial but successful use of cannabinoids for cancer and chemotherapy symptoms. Despite the fact that clinical trials are hard to conduct due to the fact of the political and social stigma of this class of drugs, this assessment gives proof of the efficacy of cannabinoids for therapy of discomfort and nausea. The final section addresses the thoughts-physique connection, with a concentrate on the adverse feelings sufferers with cancer often practical experience. This section assesses the literature with regards to mindfulness-primarily based applications to improve cancer-associated anxiety. These 3 subjects may well seem unrelated, but all address a single prevalent target: treating the physique and the thoughts to optimize good quality of life in the course of and after cancer therapy.

Copyright © 2018 Elsevier B.V. All rights reserved.

 

 

Supply:Pubmed

 

 

Teoh D1, Smith TJ1, Song M1, Spirtos NM1.